No Data
No Data
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditi
CHMP Recommends Regeneron Lymphoma Antibody Drug for Conditional Approval
Regeneron's Odronextamab Receives Opinion From EMA for Lymphoma Treatment
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommendi
Express News | Odronextamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Regeneron Pharma Is Maintained at Buy by Canaccord Genuity
Regeneron Pharma Is Maintained at Buy by Canaccord Genuity
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
On Wednesday, the FDA approved Verona Pharma plc's (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.Ohtuvayre is t
RDK79 : I recognized one word in that lead sentence:)))
But it sounds like good news!!!